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Reply to the Editor:
We appreciate Ji and Undar’s kind appraisal
of our study on the benefits of pulsatile car-
dioplegia in failing hearts, because their input
to the importance of pulsatile cardiopulmo-
nary bypass is well recognized.1 They pro-
pose that energy equivalent pressure (EEP)
and surplus hemodynamic energy (SHE)
should be reported when studying the effect
of pulsatile flow, because the difference be-
tween EEP and mean arterial pressure (MAP)
conveys the extra energy generated by each
pulsatile wave. EEP and MAP are identical
and the difference is zero when the pressure
wave is perfectly harmonic.
Our study did not report those values,2
because EEP and MAP were not signifi-
cantly different for the waveforms used. A
recent study by Huo and Kassab3 quantita-
tively demonstrated this point computa-
tionally, based on a full analysis of steady
state versus pulsatile flow in the entire cor-
onary arterial tree based on measured ana-
tomical data and experimentally to validate
the model. The inlet pressure waveform
measured from a porcine model was input
into an isolated heart to verify the model
predictions and showed excellent agree-
ment between the model and the experi-
ment. Mean flow of both pulsatile and
steady-state experiments and mathematical
model were not statistically different and
were consistent with normal heart micro-
sphere measurements.2 The EEP, MAP,
and SHE were 75.38 mm Hg, 73.54 mm
Hg and 1.84 mm Hg, respectively, provid-
ing only a 2.4% SHE/EEP ratio.
These calculations and this discussion
reflect why our study did not focus on the
EEP and SHE parameters. Rather, we be-
lieve that a different mechanism is at play
because changes occurred only in failing
hearts, because no significant changes were
found between pulsatile and nonpulsatile
cardioplegic flow existed in normal hearts.
More importantly, vascular resistance rose
in failing hearts in both the beating and
cardioplegic states (with and without pul-
sation) such that factors responsible for ini-
tiating such pulsatility effect, such as al-
tered number of vessels, lumen diameter,
and vascular length, must be understood as
ventricular geometry becomes expanded
and spherical. This pulsatility dependency
observation implies that dilated heart fail-
ure may have impaired coronary flow re-
serve capacity by limiting coronary auto-
regulation. This implication reinforces the
need to ensure increased perfusion pressure
during myocardial protection strategies
with the beating and pulsatile or nonpulsa-
tile cardioplegia delivery.
Here, a method of pulsatile cardioplegia
delivery was introduced to demonstrate the
capacity to overcome this limitation of
nonpulsatile cardioplegia in failing hearts.
Our findings underscore the value of coro-
nary pulsation, either by compression of
vessels by the beating heart or by internal
stretching by pulsatile cardioplegic flow.
Our findings support the work of Undar
relating to the significance of pulsatile flow
in the use of cardioplegia for cardiac pro-
tection. Furthermore, our observations re-
inforce the importance of studying models
that reflect clinical entities, such as heart
failure, because the observed enhancement
of subendocardial muscle perfusion would
have gone undetected in studies of normal
hearts.
Ghassan S. Kassab, PhD
Yunlong Huo, PhD
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Note: The following Reply to the Editor
refers to a letter to the editor published in a
previous issue of the Journal: Kulik A,
Rubens FD, Ruel M. Intraoperative indo-
cyanine green angiography: Ready for
prime time? J Thorac Cardiovasc Surg
2007;133:592-3.
Reply to the Editor:
We thank Dr. Kulik and colleagues for their
interest in our prospective study comparing
transit-time ultrasound flow (TTF) and indo-
cyanine green angiography (ICG).1 We ap-
preciate the opportunity to elaborate on the
three issues they raise:
1. Methods to improve visualization
with ICG angiography
2. Appropriate TTF criteria for graft
assessment
3. Cost Effectiveness
Regarding the first issue, indocyanine
green angiography is a method of fluores-
cent dye-contrast angiography that uses
near infrared laser as the energy source. We
have previously demonstrated poorer visu-
alization of thick pedicled arterial grafts
with this technique due to limited penetra-
tion of the laser into thicker tissues.2 To
improve visualization, we ensure that there
is no pedicle covering the area of the anas-
tomosis itself and we routinely expose the
native vessel for approximately 1 cm be-
yond the anastomosis. We do not skeleton-
ize the entire graft. Our evaluation of
patency is based on both anatomic visual-
ization of the anastomosis itself and
the opacification characteristics (ie, TIMI
flow) of the native circulation. Also, further
experience with the technique has led us to
perform selective angiograms directly into
the grafts which allows for improved visu-
alization of the distal anastomosis verses
injections into the central venous line
which can be confounded by native flow.2
Regarding the second issue, whereas
criteria for pulsatility index (PI) and dia-
stolic flow fraction (DFF) are standard,
there is little agreement on cut-off values
that distinguish between normal and abnor-
mal mean flow values. Although most sur-
geons would agree that a flow of less than
5 ml/min is definitely abnormal and will
often prompt revision, flows between 5 to
40 ml/min could potentially represent ab-
normal grafts. There is no clear consensus
regarding cutoff values that determine graft
problems and little prospective data on the
subject. The study by Di Giammarco and
colleagues, who recommend a 15 ml/min
mean flow cutoff, was retrospective in de-
sign.3 Because patients who had follow-up
angiograms were generally symptomatic,
their study design could not accurately as-
sess the false positive rate. The study by
Walpoth and colleagues, who recommend
a 20ml/min mean flow cutoff, had no an-
giographic controls to determine sensitivity
or specificity.4 In our study, surgeons were
permitted to intervene on any graft they
deemed to be poorly functioning, even if it
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was “normal” by the prespecified TTF cri-
teria (mean flow10 ml/min), but this did
not occur in any cases. Indeed, as clearly
stated in the manuscript, the mean flow in
abnormal (50% occluded) grafts was
24.4  8.6 ml/min and was 16.4  23.0
ml/min in grafts deemed to be totally oc-
cluded by the reference standard. In second-
ary analyses, if we used a cutoff mean flow of
15 ml/min, we would have identified no ad-
ditional true positives and 6 false positives.
Using a mean flow cutoff of 20 ml/min, we
would have identified only one additional
true positive and 10 false positives. Our
findings are in agreement with the only
other prospective comparison of these
two techniques by Taggart, who demon-
strated that up to 10% of patients may
receive erroneous graft revisions based
on false positive TTF findings.5
Hence, our cutoff value of 10 ml/min
minimizes false positives while identifying
nearly all true positives and may be an
ideal reference value when used in con-
junction with PI and DFF. Higher mean
flow cutoffs appear to have too many false
positives to be reliable measures, and many
surgeons are unlikely to revise grafts based
on higher flow values for this reason.6 This
is especially true if revision means reinstat-
ing cardiopulmonary bypass.
Finally, in regard to cost effectiveness,
we have not performed such a comparison,
because this was a clinical effectiveness
study. It is unlikely that either technology
will be highly cost effective in terms of
Quality Adjusted Life Years (QALY)
which is the generally accepted measure,
but there may be cost benefits from non-
fatal events.
Nimesh Desai, MD
Stephen E. Fremes, MD
Division of Cardiac and Vascular Surgery
Sunnybrook Health Sciences Centre
University of Toronto
Toronto, Canada
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Temporary coronary artery occlusion
during off-pump surgery and
endothelial vessel dysfunction: Is it
still an unresolved mystery?
To the Editor:
We read with great interest the article by Bou-
chot and associates.1 We would like to congrat-
ulate the authors for this well-designed study,
but we would also add some comments.
The aim was to determine the usefulness
and safety of the poloxamer P407 gel (Le-
Goo; Pluromed, Woburn, Mass) to ensure a
hemostatic effect at the anastomotic site
during off-pump surgery in a porcine
model. Twenty Landrace Yorkshire pigs,
after median sternotomy, underwent inter-
nal thoracic artery off-pump grafting to the
left anterior descending artery, the right
coronary artery, or both by using the P407
gel to control the anastomotic-site bleed-
ing. The major finding of the study was that
the intracoronary injection of P407 gel al-
lows a successful occlusion of the coronary
vessel during grafting while preserving the
endothelial function. The main limitation
of the study protocol is essentially related
to the health of the coronary artery tree
used as a benchmark. Therefore, the pres-
ence of native atherosclerotic lesions might
indicate the presence of further and other-
wise undiscovered intimal injuries.
We maintain that shunting and snaring
during off-pump coronary artery bypass
grafting are both risky procedures,2 and
thus the opportunity to use a gel effective
in bleeding control without impairing the
endothelial function might have a relevant
effect on coronary artery bypass grafting
surgery. Therefore, because there is a
higher hazard of damage to the coronary
wall during vessel manipulation with a
more diseased atherosclerotic vessel, we
suggest that testing the gel effects on the
coronary arteries of patients affected by
ischemic cardiomyopathy before heart
transplantation and before the start of car-
diopulmonary bypass should additionally
be performed.
As clinicians continuing to educate our-
selves on the benefits of new technologies,
we conclude that a more carefully con-
ducted study on a human model might re-
solve the issue of whether one technique is
more suitable than another.
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Reply to the Editor:
We thank Dr Bottio and collaborators for
their kind comments and insightful remarks
concerning our recent article in the Journal
on temporary coronary occlusion with the
new poloxamer P-417 (LeGoo; Pluromed,
Woburn, Mass) for off-pump coronary ar-
tery bypass grafting. We concur with them
that one of the limitations of the porcine
model used is the presence of normal cor-
onary endothelial coverage and function,
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